Showing results (1991-2000 of 2,036) with videos related to
Sort By:
Pageof 204
ACS Medicinal Chemistry Letters|April 16, 2020
Discovery and Optimization of Rationally Designed Bicyclic Inhibitors of Human Arginase to Enhance Cancer ImmunotherapyMatthew J Mitcheltree, Derun Li, Abdelghani Achab, et al.Cancers|September 28, 2021
Elevating CDCA3 Levels Enhances Tyrosine Kinase Inhibitor Sensitivity in TKI-Resistant EGFR Mutant Non-Small-Cell Lung CancerKatherine B Sahin, Esha T Shah, Genevieve P Ferguson, et al.Annals of Internal Medicine|October 20, 2004
Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trialRichard B Alexander, Kathleen J Propert, Anthony J Schaeffer, et al.Contemporary Clinical Trials|January 24, 2023
Rationale and design of a multisite randomized clinical trial examining an integrated behavioral treatment for veterans with co-occurring chronic pain and opioid use disorder: The pain and opioids integrated treatment in veterans (POSITIVE) trialKevin E Vowles, Katie Witkiewitz, Erik Clarke, et al.Transplantation|September 28, 2002
The nondirected live-kidney donor: ethical considerations and practice guidelines: A National Conference ReportPatricia L Adams, David J Cohen, Gabriel M Danovitch, et al.Nature|April 24, 2020
Paracrine orchestration of intestinal tumorigenesis by a mesenchymal nicheManolis Roulis, Aimilios Kaklamanos, Marina Schernthanner, et al.Journal of the American Society of Nephrology : JASN|April 20, 2019
The TiME Trial: A Fully Embedded, Cluster-Randomized, Pragmatic Trial of Hemodialysis Session DurationLaura M Dember, Eduardo Lacson, Steven M Brunelli, et al.Nature|June 12, 2024
DNA mismatch and damage patterns revealed by single-molecule sequencingMei Hong Liu, Benjamin M Costa, Emilia C Bianchini, et al.ACS Medicinal Chemistry Letters|February 20, 2020
Discovery of N-(Indazol-3-yl)piperidine-4-carboxylic Acids as RORγt Allosteric Inhibitors for Autoimmune DiseasesHongjun Zhang, Blair T Lapointe, Neville Anthony, et al.SLAS Discovery : Advancing Life Sciences R & D|August 27, 2020
Development of High-Throughput Assays for Evaluation of Hematopoietic Progenitor Kinase 1 InhibitorsBrian M Lacey, Zangwei Xu, Xiaomei Chai, et al.Pageof 204